IMVTImmunovant, Inc.Feb 6, 2026Q3 2026
Read transcript →Immunovant, Inc. (IMVT) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$33.79
+2.87%
Mkt Cap $6.49B
IMVTImmunovant, Inc.Feb 6, 2026IMVTImmunovant, Inc.Nov 12, 2025Q2 2025
Read transcript →IMVTImmunovant, Inc.Jun 9, 2022Q4 2022
Read transcript →IMVTImmunovant, Inc.Aug 9, 2021Q1 2022
Read transcript →